1-20 of 29
sodium-glucose transporter 2 inhibitors
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Association of Endocrinologists in Clinical Care Team With Sodium–Glucose Cotransporter 2 Inhibitor Prescription for People With Type 2 Diabetes After Coronary Artery Bypass Grafting: A Two-Center Study

Available to Purchase
Yangtian Yi, Nicolas Kumar, Matthew R. Smith, Ariel Mueller, Timothy Houle, Arminder Jassar, Lauren J. Cornella, Robert B. Schonberger, Amit Bardia
Journal: Clinical Diabetes
Clin Diabetes cd240107
https://doi.org/10.2337/cd24-0107
Published: 06 March 2025
View articletitled, Association of Endocrinologists in Clinical Care Team With Sodium–Glucose Cotransporter 2 Inhibitor Prescription for People With Type 2 Diabetes After Coronary Artery Bypass Grafting: A Two-Center Study
Open the PDF for Association of Endocrinologists in Clinical Care Team With Sodium–Glucose Cotransporter 2 Inhibitor Prescription for People With Type 2 Diabetes After Coronary Artery Bypass Grafting: A Two-Center Study in another window
Journal Articles

Risk of Severe Hypoglycemia After Initiation of Noninsulin Glucose-Lowering Therapies in Adults With Type 2 Diabetes at Moderate Cardiovascular Disease Risk

Available to Purchase
Rozalina G. McCoy, Kavya Sindhu Swarna, Joshua J. Neumiller, Eric C. Polley, Yihong Deng, Mindy M. Mickelson, Jeph Herrin
Journal: Clinical Diabetes
Clin Diabetes 2025;43(1):59–70
https://doi.org/10.2337/cd24-0007
Published: 13 September 2024
View articletitled, Risk of Severe Hypoglycemia After Initiation of Noninsulin Glucose-Lowering Therapies in Adults With Type 2 Diabetes at Moderate Cardiovascular Disease Risk
Open the PDF for Risk of Severe Hypoglycemia After Initiation of Noninsulin Glucose-Lowering Therapies in Adults With Type 2 Diabetes at Moderate Cardiovascular Disease Risk in another window
Journal Articles

A National Physician Survey Examining Switching From Sulfonylureas or Insulin to Newer Diabetes Medications

Available to Purchase
Scott J. Pilla, Isabelle J. Wang, Olive Tang, Nancy L. Schoenborn, Cynthia M. Boyd, Michael P. Bancks, Nestoras N. Mathioudakis, Nisa M. Maruthur
Journal: Clinical Diabetes
Clin Diabetes 2025;43(1):33–42
https://doi.org/10.2337/cd24-0043
Published: 05 September 2024
View articletitled, A National Physician Survey Examining Switching From Sulfonylureas or Insulin to Newer Diabetes Medications
Open the PDF for A National Physician Survey Examining Switching From Sulfonylureas or Insulin to Newer Diabetes Medications in another window
Journal Articles

Bexagliflozin

Free
Megan Giruzzi, Ashley Worthey
Journal: Clinical Diabetes
Clin Diabetes 2024;42(1):169–171
https://doi.org/10.2337/cd23-0085
Published: 26 October 2023
View articletitled, Bexagliflozin
Open the PDF for Bexagliflozin in another window
Journal Articles

Health Care Provider Prescribing Habits and Barriers to Use of New Type 2 Diabetes Medications: A Single-System Survey Study

Free
Aseel Yaseen, Sharon W. Lahiri
Journal: Clinical Diabetes
Clin Diabetes 2023;41(4):490–501
https://doi.org/10.2337/cd22-0100
Published: 14 April 2023
View articletitled, Health Care Provider Prescribing Habits and Barriers to Use of New Type 2 Diabetes Medications: A Single-System Survey Study
Open the PDF for Health Care Provider Prescribing Habits and Barriers to Use of New Type 2 Diabetes Medications: A Single-System Survey Study in another window
Journal Articles

Protecting the Kidneys: Update on Therapies to Treat Diabetic Nephropathy

Free
Kaylan N. Davis, Abigail E. Hines, Margaret C. Schaefer, Kristina W. Naseman
Journal: Clinical Diabetes
Clin Diabetes 2022;40(3):305–311
https://doi.org/10.2337/cd21-0090
Published: 01 July 2022
View articletitled, Protecting the Kidneys: Update on Therapies to Treat Diabetic Nephropathy
Open the PDF for Protecting the Kidneys: Update on Therapies to Treat Diabetic Nephropathy in another window
Journal Articles

Medication Optimization for New Initiators of Empagliflozin for Diabetic Kidney Disease

Free
Andrew A. Swanner, Chelsea E. Hawley, Kay Li, Laura K. Triantafylidis, Jiahua Li, Julie M. Paik
Journal: Clinical Diabetes
Clin Diabetes 2022;40(2):158–167
https://doi.org/10.2337/cd21-0078
Published: 15 April 2022
View articletitled, Medication Optimization for New Initiators of Empagliflozin for Diabetic Kidney Disease
Open the PDF for Medication Optimization for New Initiators of Empagliflozin for Diabetic Kidney Disease in another window
Journal Articles

Sodium–Glucose Cotransporter 2 Inhibitor Use Associated With Fournier’s Gangrene: A Review of Case Reports and Spontaneous Post-Marketing Cases

Free
Bao Anh Tran, Wendy H. Updike, Krystal Bullers, Erini Serag-Bolos
Journal: Clinical Diabetes
Clin Diabetes 2022;40(1):78–86
https://doi.org/10.2337/cd21-0015
Published: 01 January 2022
View articletitled, Sodium–Glucose Cotransporter 2 Inhibitor Use Associated With Fournier’s Gangrene: A Review of Case Reports and Spontaneous Post-Marketing Cases
Open the PDF for Sodium–Glucose Cotransporter 2 Inhibitor Use Associated With Fournier’s Gangrene: A Review of Case Reports and Spontaneous Post-Marketing Cases in another window
Journal Articles

Euglycemic Diabetic Ketoacidosis in a Patient Prescribed Empagliflozin and a Ketogenic Diet: A Case of Misdiagnosed Type 1 Diabetes

Free
Andrew L. Hendrickson, Xiao Q. Ye, Saminder S. Kalra, Andrew J. Franck, Daniel Urbine
Journal: Clinical Diabetes
Clin Diabetes 2021;39(1):121–123
https://doi.org/10.2337/cd20-0019
Published: 01 January 2021
View articletitled, Euglycemic Diabetic Ketoacidosis in a Patient Prescribed Empagliflozin and a Ketogenic Diet: A Case of Misdiagnosed Type 1 Diabetes
Open the PDF for Euglycemic Diabetic Ketoacidosis in a Patient Prescribed Empagliflozin and a Ketogenic Diet: A Case of Misdiagnosed Type 1 Diabetes in another window
Journal Articles

Optimizing Management of Type 2 Diabetes and Its Complications in Patients With Heart Failure

Free
Christie A. Schumacher, Elizabeth K. Van Dril, Kayce M. Shealy, Jennifer D. Goldman
Journal: Clinical Diabetes
Clin Diabetes 2021;39(1):105–116
https://doi.org/10.2337/cd20-0008
Published: 01 January 2021
View articletitled, Optimizing Management of Type 2 Diabetes and Its Complications in Patients With Heart Failure
Open the PDF for Optimizing Management of Type 2 Diabetes and Its Complications in Patients With Heart Failure in another window
Journal Articles

Patient and Provider Characteristics Associated With Sodium–Glucose Cotransporter 2 Inhibitor Prescription in Patients With Diabetes and Proteinuric Chronic Kidney Disease

Free
Ian E. McCoy, Jialin Han, Maria E. Montez-Rath, Glenn M. Chertow, Jinnie J. Rhee
Journal: Clinical Diabetes
Clin Diabetes 2020;38(3):240–247
https://doi.org/10.2337/cd19-0087
Published: 01 July 2020
View articletitled, Patient and Provider Characteristics Associated With Sodium–Glucose Cotransporter 2 Inhibitor Prescription in Patients With Diabetes and Proteinuric Chronic Kidney Disease
Open the PDF for Patient and Provider Characteristics Associated With Sodium–Glucose Cotransporter 2 Inhibitor Prescription in Patients With Diabetes and Proteinuric Chronic Kidney Disease in another window
Journal Articles

A Case of Euglycemic Diabetic Ketoacidosis Triggered by a Ketogenic Diet in a Patient With Type 2 Diabetes Using a Sodium–Glucose Cotransporter 2 Inhibitor

Free
Paola Sanchez Garay, Gabriela Zuniga, Robert Lichtenberg
Journal: Clinical Diabetes
Clin Diabetes 2020;38(2):204–207
https://doi.org/10.2337/cd19-0055
Published: 01 April 2020
View articletitled, A Case of Euglycemic Diabetic Ketoacidosis Triggered by a Ketogenic Diet in a Patient With Type 2 Diabetes Using a Sodium–Glucose Cotransporter 2 Inhibitor
Open the PDF for A Case of Euglycemic Diabetic Ketoacidosis Triggered by a Ketogenic Diet in a Patient With Type 2 Diabetes Using a Sodium–Glucose Cotransporter 2 Inhibitor in another window
Journal Articles

Sodium–Glucose Cotransporter 2 Inhibitor–Associated Prolonged Euglycemic Diabetic Ketoacidosis in Type 2 Diabetes: A Case Report and Literature Review

Open Access
Ahmad Yehya, Archana Sadhu
Journal: Clinical Diabetes
Clin Diabetes 2020;38(1):112–116
https://doi.org/10.2337/cd19-0035
Published: 01 January 2020
View articletitled, Sodium–Glucose Cotransporter 2 Inhibitor–Associated Prolonged Euglycemic Diabetic Ketoacidosis in Type 2 Diabetes: A Case Report and Literature Review
Open the PDF for Sodium–Glucose Cotransporter 2 Inhibitor–Associated Prolonged Euglycemic Diabetic Ketoacidosis in Type 2 Diabetes: A Case Report and Literature Review in another window
Journal Articles

Putting Heart (and Kidneys) Into Diabetes Care

Open Access
Stephen Brunton
Journal: Clinical Diabetes
Clin Diabetes 2019;37(4):314–315
https://doi.org/10.2337/cd19-0054
Published: 01 October 2019
View articletitled, Putting Heart (and Kidneys) Into Diabetes Care
Open the PDF for Putting Heart (and Kidneys) Into Diabetes Care in another window
Journal Articles

Cardiovascular Outcome Trials in Type 2 Diabetes: What Do They Mean for Clinical Practice?

Open Access
Robert H. Eckel, Azeez Farooki, Robert R. Henry, Gary G. Koch, Lawrence A. Leiter
Journal: Clinical Diabetes
Clin Diabetes 2019;37(4):316–337
https://doi.org/10.2337/cd19-0001
Published: 01 October 2019
View articletitled, Cardiovascular Outcome Trials in Type 2 Diabetes: What Do They Mean for Clinical Practice?
Open the PDF for Cardiovascular Outcome Trials in Type 2 Diabetes: What Do They Mean for Clinical Practice? in another window
Journal Articles

Sodium–Glucose Cotransporter 2 Inhibitor Protection Against Adverse Cardiovascular and Renal Outcomes in Patients With Type 2 Diabetes

Open Access
Edward Shahady, John L. Leahy
Journal: Clinical Diabetes
Clin Diabetes 2019;37(3):211–220
https://doi.org/10.2337/cd18-0064
Published: 01 July 2019
View articletitled, Sodium–Glucose Cotransporter 2 Inhibitor Protection Against Adverse Cardiovascular and Renal Outcomes in Patients With Type 2 Diabetes
Open the PDF for Sodium–Glucose Cotransporter 2 Inhibitor Protection Against Adverse Cardiovascular and Renal Outcomes in Patients With Type 2 Diabetes in another window
Journal Articles

Importance of Postprandial Glucose in Relation to A1C and Cardiovascular Disease

Open Access
Kenneth S. Hershon, Barbara R. Hirsch, Ola Odugbesan
Journal: Clinical Diabetes
Clin Diabetes 2019;37(3):250–259
https://doi.org/10.2337/cd18-0040
Published: 01 July 2019
View articletitled, Importance of Postprandial Glucose in Relation to A1C and Cardiovascular Disease
Open the PDF for Importance of Postprandial Glucose in Relation to A1C and Cardiovascular Disease in another window
Journal Articles

Overview of Ertugliflozin

Open Access
Vivianne K. Nguyen, John R. White, Jr
Journal: Clinical Diabetes
Clin Diabetes 2019;37(2):176–178
https://doi.org/10.2337/cd18-0097
Published: 01 April 2019
View articletitled, Overview of Ertugliflozin
Open the PDF for Overview of Ertugliflozin in another window
Journal Articles

Nonglycemic Outcomes of Antidiabetic Medications

Open Access
Christopher Morse, David Sze, Dhiren Patel, Jennifer Goldman
Journal: Clinical Diabetes
Clin Diabetes 2019;37(2):131–141
https://doi.org/10.2337/cd18-0015
Published: 01 April 2019
View articletitled, Nonglycemic Outcomes of Antidiabetic Medications
Open the PDF for Nonglycemic Outcomes of Antidiabetic Medications in another window
Journal Articles

Timely News and Notes for Primary Care Providers from the American Diabetes Association

Open Access
Max Bingham, PhD
Journal: Clinical Diabetes
Clin Diabetes 2019;37(2):100–104
https://doi.org/10.2337/cd19-0010
Published: 01 April 2019
View articletitled, Timely News and Notes for Primary Care Providers from the American Diabetes Association
Open the PDF for Timely News and Notes for Primary Care Providers from the American Diabetes Association in another window